Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer

NCT00645177 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: ABT-869
DRUG: paclitaxel
DRUG: Placebo for ABT-869

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]